banner add

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

June 11, 2024 0
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

from NYT > Health https://ift.tt/dTJFvE7
via IFTTT
Tags:

No comments

Subscribe to: Post Comments ( Atom )

U.S. Officials Expected to Announce Cyclospora Outbreak Is Over

More than 11,000 cases of the illness had been linked to lettuce from Taylor Farms that was processed in Mexico. An investigation into how t...

Theme images by PLAINVIEW. Powered by Blogger.